Incyte (INCY) Buildings (2018)

Incyte (INCY) posted Buildings of $37.5 million for Q4 2018.

Incyte (INCY) Buildings (2018) Analysis & Trends

Incyte's Buildings history runs 1 years deep, the most recent figure standing at $37.5 million for Q4 2018.

Quarterly Buildings changed N/A year-over-year to $37.5 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $37.5 million (changed N/A YoY) and the FY2018 annual result came in at $37.5 million, changed N/A from the prior year.
Buildings was $37.5 million for Q4 2018 at Incyte.
Across five years, Buildings topped out at $37.5 million in Q4 2018 and bottomed at $37.5 million in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Incyte	23.33 Bn	19.32 Bn	1.17 Bn

Historic Data

Download Data

Date	Value
Dec 31, 2018	37.50 Mn